Pfizer has decided to relocate its New York City headquarters to a new building in the city. The company signed a 20-year lease for The Spiral, an office tower being built at Hudson Yards of Manhattan.

As part of its 20-year lease agreement, Pfizer will relocate its global headquarters from East 42nd Street to The Spiral, where it will occupy 15 floors, and expects to begin moving employees there in 2022. Pfizer is currently in the process of selling its headquarters property on East 42nd Street, which it has occupied since 1961.

“In relocating our headquarters, we sought to provide our colleagues a modern, state-of-the-art headquarters that would foster greater collaboration and innovation in a vibrant neighborhood in Manhattan,” said Albert Bourla, Pfizer Chief Operating Officer in an April 10, 2018 company statement. 

Source: Pfizer